Murray Stahl's LTRN Position Overview
Murray Stahl (via Horizon Kinetics Asset Management LLC) currently holds 25,164 shares of Lantern Pharma Inc. (LTRN) worth $104,934, representing 0.00% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Murray Stahl has maintained a strategic position in LTRN, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 1,209 shares. Largest reduction occurred in Q4 2023, reducing 1,209 shares.
Analysis based on 13F filings available since 2013 Q2
Murray Stahl's Lantern Pharma (LTRN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Lantern Pharma (LTRN) Trades by Murray Stahl
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -1,209 | Reduce 4.58% | 25,164 | $4.17 |
| Q1 2026 | -1,209 | Reduce 4.38% | 26,373 | $1.37 |
| Q4 2025 | -1,209 | Reduce 4.20% | 27,582 | $3.03 |
| Q3 2025 | +1,209 | Add 4.38% | 28,791 | $4.35 |
| Q2 2025 | -1,209 | Reduce 4.20% | 27,582 | $3.16 |
| Q4 2024 | +1,209 | Add 4.38% | 28,791 | $3.19 |
| Q3 2024 | -1,209 | Reduce 4.20% | 27,582 | $3.67 |
| Q4 2023 | -1,209 | Reduce 4.03% | 28,791 | $4.28 |
| Q1 2023 | +30,000 | New Buy | 30,000 | $4.83 |
Murray Stahl's Lantern Pharma Investment FAQs
Murray Stahl first purchased Lantern Pharma Inc. (LTRN) in Q1 2023, acquiring 30,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl has held Lantern Pharma Inc. (LTRN) for 14 quarters since Q1 2023.
Murray Stahl's largest addition to Lantern Pharma Inc. (LTRN) was in Q1 2023, adding 30,000 shares worth $144,900.
According to the latest 13F filing for Q2 2026, Murray Stahl's firm, Horizon Kinetics Asset Management LLC, owns 25,164 shares of Lantern Pharma Inc. (LTRN), valued at approximately $104,934.
As of the Q2 2026 filing, Lantern Pharma Inc. (LTRN) represents approximately 0.00% of Murray Stahl's publicly disclosed stock portfolio, making it one of their key holdings.
Murray Stahl's peak holding in Lantern Pharma Inc. (LTRN) was 30,000 shares, as reported at the end of Q1 2023.